Abstract
Bruceantin (1), a classical quassinoid with the highest reported antimalarial activity among the quassinoids examined thus far, was selected as a natural product lead for the design of a series of A/B-ring analogs. A viable strategy for the synthesis of the series was developed. The functionalized A-ring and the C-15 ester moiety in bruceantin are incorporated in all designed compounds. The preliminary bioassay results will be discussed in detail.
Keywords: bruceantin, partial analogs, bioassay, structure activity relationships, antileukemic and antimalarial activities
Medicinal Chemistry
Title: Synthesis of A/B-Ring Partial Analogs of Bruceantin as Potential Antimalarial Agents
Volume: 1 Issue: 1
Author(s): Z. Guo, S. Vangapandu, A. Nimrod, L. A. Walker and R. D. Sindelar
Affiliation:
Keywords: bruceantin, partial analogs, bioassay, structure activity relationships, antileukemic and antimalarial activities
Abstract: Bruceantin (1), a classical quassinoid with the highest reported antimalarial activity among the quassinoids examined thus far, was selected as a natural product lead for the design of a series of A/B-ring analogs. A viable strategy for the synthesis of the series was developed. The functionalized A-ring and the C-15 ester moiety in bruceantin are incorporated in all designed compounds. The preliminary bioassay results will be discussed in detail.
Export Options
About this article
Cite this article as:
Guo Z., Vangapandu S., Nimrod A., Walker A. L. and Sindelar D. R., Synthesis of A/B-Ring Partial Analogs of Bruceantin as Potential Antimalarial Agents, Medicinal Chemistry 2005; 1 (1) . https://dx.doi.org/10.2174/1573406053402488
DOI https://dx.doi.org/10.2174/1573406053402488 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients
Current Pharmaceutical Biotechnology Cyclotron Production of PET Radiometals in Liquid Targets: Aspects and Prospects
Current Radiopharmaceuticals Melanoma: Prognostic Factors and Factors Predictive of Response to Therapy
Current Medicinal Chemistry Antitumor Titanium Compounds
Mini-Reviews in Medicinal Chemistry Fucose Specific Lectins in Cancer Research and Diagnosis
Drug Design Reviews - Online (Discontinued) Functions of Polo-Like Kinases: A Journey From Yeast To Humans
Protein & Peptide Letters Targeted Therapy for Advanced Renal Cell Cancer: Cytokines and Beyond
Current Pharmaceutical Design Lysophospholipase D/Autotaxin in Lysophospholipid Biology
Current Enzyme Inhibition HGF-Antagonists: Structure, Activities, and Anti-cancer Approach
Current Signal Transduction Therapy Immunotherapy for Malignant Melanoma Robert
Current Stem Cell Research & Therapy CCL2-CCR2 Signaling in Disease Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Therapeutic Agents Based on DNA Sequence Specific Binding
Current Topics in Medicinal Chemistry PreQ<sub>0</sub> Base, an Unusual Metabolite with Anti-cancer Activity from Streptomyces qinglanensis 172205
Anti-Cancer Agents in Medicinal Chemistry Radioimmunotherapy of Infection with 213Bi-Labeled Antibodies
Current Radiopharmaceuticals Spongistatins as Tubulin Targeting Agents
Current Pharmaceutical Design Pathobiology of Stent Thrombosis after Drug-Eluting Stent Implantation
Current Pharmaceutical Design LHRH-Targeted Drug Delivery Systems for Cancer Therapy
Mini-Reviews in Medicinal Chemistry Deregulation of HOX B13 Expression in Urinary Bladder Cancer Progression
Current Medicinal Chemistry Specific Targeted Therapy: A New Tool for the Destruction of Cancer
Current Drug Therapy Anti-Cancer/Anti-Tumor
Current Bioactive Compounds